Virtual screening software for cancer research

Cresset, the provider of software and contract research services for small molecule discovery and design, says Cancer Therapeutics CRC (CTx), a collaborative partnership of l research institutes, universities and biotechnology companies in Australia, has licensed the virtual screening software Blaze for cancer research.

Blaze will be used to run virtual screening projects to translate Australia’s innovative research discoveries into new cancer drugs.

Says Warwick Tong, Chief Executive Officer at CTx: “With access to a super computer at the Commonwealth Scientific and Industrial Research Organization (CSIRO) we now have the capability to run virtual screening projects not just for CTx but also as a service to all Australian academics. We look forward to working with academics and post-docs and providing them access to this impressive resource.”

Recent Issues